urea and quetiapine fumarate

urea has been researched along with quetiapine fumarate in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Brammer, MJ; Brown, RG; Jones, HM; O'Toole, M; Ohlsen, RI; Pilowsky, LS; Purvis, R; Taylor, T; Williams, S1
Eksanow, K; Glice, M; Kaczmarek, L; Kubiszewski, M; Kutner, A; Stolarczyk, EU1
Hacksell, U; Hubbard, D; McFarland, K1
Chitnis, S; Khemani, P; Patel, N; Samudra, N; Womack, KB1
Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ1
Cozac, VV1
Friedman, JH1
Gandhi, R; Lessig, SL; Litvan, I; Moreno, GM; Nahab, FB; Wright, B1
Dahodwala, N; Horn, S; Richardson, H; Weintraub, D; Xie, SX1
Alakkas, A; Liu, L; Longardner, K; Nahab, FB; Wright, BA; Xu, R; You, H1

Reviews

3 review(s) available for urea and quetiapine fumarate

ArticleYear
Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.
    Drugs & aging, 2016, Volume: 33, Issue:12

    Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Humans; Molecular Targeted Therapy; Neurotransmitter Agents; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Urea

2016
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    The Annals of pharmacotherapy, 2017, Volume: 51, Issue:8

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea

2017
Pharmacological interventions for psychosis in Parkinson's disease patients.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:5

    Topics: Antipsychotic Agents; Clozapine; Dopamine; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Urea

2018

Trials

1 trial(s) available for urea and quetiapine fumarate

ArticleYear
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study.
    Biological psychiatry, 2004, Dec-15, Volume: 56, Issue:12

    Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Brain Mapping; Carbamide Peroxide; Cerebral Cortex; Cognition; Dibenzothiazepines; Drug Combinations; Female; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peroxides; Quetiapine Fumarate; Reaction Time; Schizophrenia; Urea; Verbal Learning

2004

Other Studies

6 other study(ies) available for urea and quetiapine fumarate

ArticleYear
Identification and characterization of potential impurities of quetiapine fumarate.
    Pharmaceutical development and technology, 2009, Volume: 14, Issue:1

    Topics: Aniline Compounds; Antipsychotic Agents; Carbamates; Dibenzothiazepines; Drug Contamination; Magnetic Resonance Spectroscopy; Mass Spectrometry; Phenylurea Compounds; Piperazines; Quetiapine Fumarate; Spectrophotometry, Infrared; Sulfides; Thiazepines; Urea

2009
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
    Behavioural pharmacology, 2013, Volume: 24, Issue:7

    Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Parkinsonian Disorders; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Urea

2013
[Modern approaches to treatment of psychosis in Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2016, Volume: 116, Issue:10

    Topics: Antiparkinson Agents; Antipsychotic Agents; Clozapine; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Urea

2016
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology, 2018, 10-23, Volume: 91, Issue:17

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Survival Analysis; Treatment Outcome; Urea

2018
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Parkinsonism & related disorders, 2019, Volume: 69

    Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea

2019
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
    PloS one, 2023, Volume: 18, Issue:1

    Topics: Aged; Antipsychotic Agents; Dementia; Humans; Levodopa; Parkinson Disease; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea

2023